Bortezomib-Mediated Inhibition of Steroid Receptor Coactivator-3 Degradation Leads to Activated AktGustavo Ayala(The University of Texas Health Science Center at Houston), Dov Kadmon(Neurology, Inc)Clinical Cancer ResearchNovember 14, 200810.1158/1078-0432.ccr-08-0839Cited by 29SaveCiteExport RISWatch citationsRelated PapersNeuropeptide Y nerve paracrine regulation of prostate cancer oncogenesis and therapy resistance|The Prostate|2020|39